Literature DB >> 31472258

Piper diospyrifolium Kunth.: Chemical analysis and antimicrobial (intrinsic and combined) activities.

Joara Nályda Pereira Carneiro1, Rafael Pereira da Cruz1, Josefa Carolaine Pereira da Silva1, Janaína Esmeraldo Rocha1, Thiago Sampaio de Freitas1, Débora Lima Sales1, Camila Fonseca Bezerra1, Waltécio de Oliveira Almeida1, José Galberto Martins da Costa1, Luiz Everson da Silva2, Wanderlei do Amaral2, Ricardo Andrade Rebelo3, Ieda Maria Begnini3, Henrique Douglas Melo Coutinho4, Maria Flaviana Bezerra Morais-Braga1.   

Abstract

The secular use of plants in popular medicine has emerged as a source for the discovery of new compounds capable of curing infections. Among microbial resistance to commercial drugs, species such as Piper diospyrifolium Kunth, which are used in popular therapy, are targets for pharmacological studies. With this in mind, antimicrobial experiments with the essential oil from the P. diospyrifolium (PDEO) species were performed and its constituents were elucidated. The oil compounds were identified by gas chromatography coupled to mass spectrometry (GC/MS). The broth microdilution method with colorimetric readings for bacterial tests (Escherichia coli and Staphylococcus aureus) and spectrophotometric readings for fungal tests (Candida albicans and Candida tropicalis), whose data were used to create a cell viability curve and calculate its IC50 against fungal cells, were used to determine the minimum inhibitory concentration of the oil and its combined action with commercial drugs. The oil's minimal fungicidal concentration and its action over fungal morphological transition were analyzed by subculture and microculture, respectively. Chemical analysis revealed Z-Carpacin, Pogostol and E-Caryophyllene as the most abundant compounds. Results from the intrinsic analysis were considered clinically irrelevant, however the oil presented a synergistic effect against multiresistant E. coli and S. aureus strains when associated with gentamicin, and against the standard and isolated C. tropicalis strains with fluconazole. A fungicidal effect was observed against the C. albicans isolate. Candida spp. hyphae inhibition was verified for all strains at the highest tested concentrations. The P. diospyrifolium essential oil presented a promising effect when associated with commercial drugs and against a fungal virulence factor. Thus, the oil presented active compounds which may help the development of new drugs, however, new studies are needed in order to clarify the oil's mechanism of action, as well as to identify its active constituents.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell viability; Escherichia coli; Fluconazole; Synergism; Virulence; Z-Carpacin

Mesh:

Substances:

Year:  2019        PMID: 31472258     DOI: 10.1016/j.micpath.2019.103700

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  2 in total

1.  Lectins ConA and ConM extracted from Canavalia ensiformis (L.) DC and Canavalia rosea (Sw.) DC inhibit planktonic Candida albicans and Candida tropicalis.

Authors:  Victor Juno Alencar Fonseca; Ana Lays Braga; Ray Silva de Almeida; Taís Gusmão da Silva; Josefa Carolaine Pereira da Silva; Luciene Ferreira de Lima; Maria Helena Cruz Dos Santos; Romério Rodrigues Dos Santos Silva; Claudener Souza Teixeira; Henrique Douglas Melo Coutinho; Maria Flaviana Bezerra Morais-Braga
Journal:  Arch Microbiol       Date:  2022-05-24       Impact factor: 2.667

2.  Anti-Candida Properties of Gossypium hirsutum L.: Enhancement of Fungal Growth, Biofilm Production and Antifungal Resistance.

Authors:  Luciene Ferreira de Lima; Jacqueline Cosmo Andrade-Pinheiro; Maria Audilene Freitas; Adriely Idalina da Silva; Victor Juno Alencar Fonseca; Taís Gusmão da Silva; Josefa Carolaine Pereira da Silva; Rosilaine Honorato de Lima; Débora Lima Sales; Rejane Pereira Neves; Edy Sousa de Brito; Paulo Riceli Vasconcelos Ribeiro; Kirley Marques Canuto; Henrique Douglas Melo Coutinho; Abolghasem Siyadatpanah; Bonglee Kim; Maria Flaviana Bezerra Morais-Braga
Journal:  Pharmaceutics       Date:  2022-03-24       Impact factor: 6.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.